skip-to-main

Spikevax (previously COVID‑19 Vaccine Moderna)

Great Britain
A Conditional Marketing Authorisation (CMA) has been granted in the UK for Spikevax (previously COVID‑19 Vaccine Moderna) to prevent coronavirus disease 2019 (COVID‑19) in people from 6 years of age.

Northern Ireland
A Conditional Marketing Authorisation (CMA) has been granted in the EU for Spikevax (previously COVID‑19 Vaccine Moderna) to prevent coronavirus disease 2019 (COVID‑19) in people from 6 years of age.

Great Britain
Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Dear Healthcare Professional

Dear Healthcare Professional

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Northern Ireland
Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Storage, Handling, Dosage and Administration

Storage, Handling, Dosage and Administration

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna